autoimmune hepatitis

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • type 1
    • most common form in USA
    • occurs in young women (20-40 years), less often postmenopausal women
  • type 2

Pathology

Clinical manifestations

Laboratory

Complications

Differential diagnosis

* may be associated with extreme elevations in serum transaminases

Management

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  2. 2.0 2.1 ARUP Consult: Autoimmune Hepatitis The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/autoimmune-hepatitis
  3. Manns MP, Czaja AJ, Gorham JD, Krawitt EL et al Diagnosis and management of autoimmune hepatitis. Hepatology. 2010 Jun;51(6):2193-213 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20513004 (corresponding NGC guideline withdrawn Nov 2015)
  4. 4.0 4.1 4.2 4.3 4.4 NEJM Knowledge+ Gastroenterology
  5. 5.0 5.1 Krawitt EL Autoimmune hepatitis N Engl J Med 2006;354:54-66. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16394302 https://www.nejm.org/doi/pdf/10.1056/NEJMra050408
  6. 6.0 6.1 Mack CL, Adams D, Assis DN et al Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020 Aug;72(2):671-722. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31863477 No abstract available.
  7. Autoimmune Hepatitis https://www.niddk.nih.gov/health-information/liver-disease/autoimmune-hepatitis

Patient information

autoimmune hepatitis patient information